Imvaria
Healthcare Software · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
441 Palo Alto Ave, Mountain View, Califo...Website
www.imvaria.comRevenue
<$5 MillionIndustry
About Imvaria
IMVARIA Inc. is a health tech company specializing in AI-driven digital biomarker solutions that enhance clinical decision-making for earlier and more accurate diagnoses of diseases, particularly in lung conditions like idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD). Founded in 2019 by physician-engineers from Google and Stanford University, the company has developed FDA-authorized tools such as Fibresolve and ScreenDx, which provide non-invasive diagnostic support for clinicians. IMVARIA aims to reduce the need for invasive biopsy testing while improving patient outcomes through innovative AI technology. The company serves healthcare professionals, particularly pulmonologists, by offering advanced diagnostic solutions that integrate seamlessly into existing workflows.Explore more
Imvaria Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Imvaria
Compare insights from companies similar to Imvaria, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2007
JB
Jeannette BakkenNetwork Administrator & Clinical Database Programmer & Contractor
Imvaria Tech Stack
A closer look at the technologies used by Imvaria
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Imvaria
Sign Up For FreeTo access detailed company insights
IMVARIA Inc. is a health tech company specializing in AI-driven digital biomarker solutions that enhance clinical decision-making for earlier and more accurate diagnoses of diseases, particularly in lung conditions like idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD). Founded in 2019 by physician-engineers from Google and St... Read More
